Erythropoietin, aluminium, and anaemia in patients on haemodialysis

Lancet. 1990 Feb 3;335(8684):247-9. doi: 10.1016/0140-6736(90)90067-f.

Abstract

Effects of erythropoietin treatment on haem synthesis in peripheral blood were evaluated in 11 patients on haemodialysis. After 2 weeks of erythropoietin, mean (SEM) uroporphyrinogen-l synthase activity increased significantly from 88 (10) to 116 (9) pmol/h per mg protein. Haem synthase activity, thought to be the rate-limiting step in erythroid haem synthesis, also showed a significant increase from 4.5 (0.8) to 8.4 (1.8) pmol/h per 10(6) reticulocytes. 4 patients, who showed only a partial response to erythropoietin, had significantly higher serum aluminium concentrations than the 7 who responded fully (225 [44] vs 55 [23] micrograms/l); erythrocyte protoporphyrin concentrations in partial responders were also much higher than in responders (973 [120] vs 388 [29] nmol/l). Aluminium intoxication may cause resistance to erythropoietin by interference with haem synthesis, with accumulation of protoporphyrin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aluminum / adverse effects*
  • Aluminum / blood
  • Anemia, Hypochromic / blood
  • Anemia, Hypochromic / chemically induced*
  • Deferoxamine / administration & dosage
  • Deferoxamine / therapeutic use
  • Drug Evaluation
  • Drug Resistance
  • Drug Therapy, Combination
  • Erythrocyte Count / drug effects
  • Erythrocytes / chemistry
  • Erythrocytes / enzymology*
  • Erythropoiesis / drug effects*
  • Erythropoietin / administration & dosage
  • Erythropoietin / pharmacology*
  • Female
  • Ferrochelatase / blood*
  • Humans
  • Hydroxymethylbilane Synthase / blood
  • Lyases / blood*
  • Male
  • Middle Aged
  • Protoporphyrins / blood
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Renal Dialysis*

Substances

  • Protoporphyrins
  • Recombinant Proteins
  • Erythropoietin
  • Aluminum
  • Hydroxymethylbilane Synthase
  • Lyases
  • Ferrochelatase
  • Deferoxamine